Xofigo - supply shortage

Resolved

radium Ra223 dichloride

Shortage information

The shortage affecting Xofigo has been resolved and the information and recommendations which were issued during the shortage no longer apply.

Key facts

• Medicines affected:
  Xofigo
• Supply shortage status:
  Resolved
• International non-proprietary name (INN) or common name:
  radium Ra223 dichloride
• Therapeutic area (MESH):
  Prostatic Neoplasms
• Pharmaceutical forms affected:
  Solution for injection
• Strengths affected:
  1100 kBq/ml
• Availability of alternatives:
  No

Key dates

• First published:
  17/10/2014
• Last updated:
  30/04/2015